TY - JOUR T1 - Recruitment for psychological therapy in chronic obstructive pulmonary disease (COPD) What factors influence participation? JF - European Respiratory Journal JO - Eur Respir J VL - 42 IS - Suppl 57 SP - P3655 AU - Karen Heslop AU - Chris Stenton AU - Michelle Jambon AU - Julia Newton AU - Debbie Carrick-Sen AU - Chris Baker AU - Graham Burns AU - Anthony De Soyza Y1 - 2013/09/01 UR - http://erj.ersjournals.com/content/42/Suppl_57/P3655.abstract N2 - Aims and ObjectivesThis prospective study compared patients with COPD who participated in a randomised controlled trial (RCT) of cognitive behavioural therapy (CBT) delivered by respiratory nurses with those who were eligible but declined.MethodsPatients with COPD attending out-patient respiratory clinics were screened for symptoms of anxiety using the Hospital Anxiety & Depression Score (HADS). Patients with HADS score ≥8 for anxiety were invited to participate in a RCT of CBT.Participants in the RCT were compared with those who were eligible but had declined participation in the study. Data including gender, age, COPD severity (as per NICE Criteria, 2010), anxiety and depression scores were analysed using Chi-Square tests and linear regression.ResultsIn total data from 336 patients were analysed. 174 patients were recruited to the study compared to 162 patients were eligible but declined. There were no gender differences between those who participated and those who declined (Chi-Square = 2.015, DF = 1, p>0.1). Those recruited were on average 3 years younger (p<0.01). Their COPD severity scores were no different (likelihood ratio Chi-Square = 5.120, DF = 3, p>0.1). They were not more anxious (t = -0.57 p>0.5) but they were more depressed (t= -2.05 p<0.05).ConclusionThere are recognised difficulties in recruiting patients with COPD for non-pharmacological treatments such as pulmonary rehabilitation. We have shown that younger patients and those who more depressed are more likely to agree to a study involving psychological treatment. Further analysis of why patients decline potentially beneficial treatments and novel strategies to engage them are needed. ER -